Assertio Therapeutics (ASRT) PT Raised to $9.50 at Roth/MKM

March 9, 2023 6:17 AM EST Send to a Friend

Roth/MKM analyst Scott Henry raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Assertio Therapeutics (ASRT) PT Raised to $9.50 at Roth/MKM

Member Login

Free News Feed